• Home
  • Pharmaceuticals and Healthcare
Parkinson Disease Drug Market - Global Outlook and Forecast 2021-2027

Parkinson Disease Drug Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ777247 | No. of Pages: 102 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Jun-2021 
This report contains market size and forecasts of Parkinson Disease Drug in Global, including the following market information:
Global Parkinson Disease Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Parkinson Disease Drug market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Parkinson Disease Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Parkinson Disease Drug Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Parkinson Disease Drug Market Segment Percentages, By Type, 2020 (%)
    Sinemet-CR
    Trastal
    Madopar
    COMT Inhibitor
    Other

China Parkinson Disease Drug Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Parkinson Disease Drug Market Segment Percentages, By Application, 2020 (%)
    Under 40 Years Old
    40-65 Years Old
    Above 65 Years Old

Global Parkinson Disease Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Parkinson Disease Drug Market Segment Percentages, By Region and Country, 2020 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Parkinson Disease Drug Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Parkinson Disease Drug Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
    Merck
    Akorn
    GSK
    Novartis
    Boehringer Ingelheim
    Teva Pharmaceutical
    Abbvie
    Kyowa Hakko Kirin Pharma
    Astellas Pharma
    Desitin Arzneimittel
    Endo Pharmaceuticals
    F.Hoffmann-La Roche
    H.Lundbeck
    Valeant
    Apokyn
    Orion
    Stada Arzneimittel
    US WorldMeds
    Bausch Health
1 Introduction to Research & Analysis Reports
    1.1 Parkinson Disease Drug Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Parkinson Disease Drug Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Parkinson Disease Drug Overall Market Size
    2.1 Global Parkinson Disease Drug Market Size: 2021 VS 2027
    2.2 Global Parkinson Disease Drug Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Parkinson Disease Drug Players in Global Market
    3.2 Top Global Parkinson Disease Drug Companies Ranked by Revenue
    3.3 Global Parkinson Disease Drug Revenue by Companies
    3.4 Top 3 and Top 5 Parkinson Disease Drug Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Parkinson Disease Drug Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Parkinson Disease Drug Players in Global Market
        3.6.1 List of Global Tier 1 Parkinson Disease Drug Companies
        3.6.2 List of Global Tier 2 and Tier 3 Parkinson Disease Drug Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Parkinson Disease Drug Market Size Markets, 2021 & 2027
        4.1.2 Sinemet-CR
        4.1.3 Trastal
        4.1.4 Madopar
        4.1.5 COMT Inhibitor
        4.1.6 Other
    4.2 By Type - Global Parkinson Disease Drug Revenue & Forecasts
        4.2.1 By Type - Global Parkinson Disease Drug Revenue, 2016-2021
        4.2.2 By Type - Global Parkinson Disease Drug Revenue, 2022-2027
        4.2.3 By Type - Global Parkinson Disease Drug Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Parkinson Disease Drug Market Size, 2021 & 2027
        5.1.2 Under 40 Years Old
        5.1.3 40-65 Years Old
        5.1.4 Above 65 Years Old
    5.2 By Application - Global Parkinson Disease Drug Revenue & Forecasts
        5.2.1 By Application - Global Parkinson Disease Drug Revenue, 2016-2021
        5.2.2 By Application - Global Parkinson Disease Drug Revenue, 2022-2027
        5.2.3 By Application - Global Parkinson Disease Drug Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Parkinson Disease Drug Market Size, 2021 & 2027
    6.2 By Region - Global Parkinson Disease Drug Revenue & Forecasts
        6.2.1 By Region - Global Parkinson Disease Drug Revenue, 2016-2021
        6.2.2 By Region - Global Parkinson Disease Drug Revenue, 2022-2027
        6.2.3 By Region - Global Parkinson Disease Drug Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Parkinson Disease Drug Revenue, 2016-2027
        6.3.2 US Parkinson Disease Drug Market Size, 2016-2027
        6.3.3 Canada Parkinson Disease Drug Market Size, 2016-2027
        6.3.4 Mexico Parkinson Disease Drug Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Parkinson Disease Drug Revenue, 2016-2027
        6.4.2 Germany Parkinson Disease Drug Market Size, 2016-2027
        6.4.3 France Parkinson Disease Drug Market Size, 2016-2027
        6.4.4 U.K. Parkinson Disease Drug Market Size, 2016-2027
        6.4.5 Italy Parkinson Disease Drug Market Size, 2016-2027
        6.4.6 Russia Parkinson Disease Drug Market Size, 2016-2027
        6.4.7 Nordic Countries Parkinson Disease Drug Market Size, 2016-2027
        6.4.8 Benelux Parkinson Disease Drug Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Parkinson Disease Drug Revenue, 2016-2027
        6.5.2 China Parkinson Disease Drug Market Size, 2016-2027
        6.5.3 Japan Parkinson Disease Drug Market Size, 2016-2027
        6.5.4 South Korea Parkinson Disease Drug Market Size, 2016-2027
        6.5.5 Southeast Asia Parkinson Disease Drug Market Size, 2016-2027
        6.5.6 India Parkinson Disease Drug Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Parkinson Disease Drug Revenue, 2016-2027
        6.6.2 Brazil Parkinson Disease Drug Market Size, 2016-2027
        6.6.3 Argentina Parkinson Disease Drug Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Parkinson Disease Drug Revenue, 2016-2027
        6.7.2 Turkey Parkinson Disease Drug Market Size, 2016-2027
        6.7.3 Israel Parkinson Disease Drug Market Size, 2016-2027
        6.7.4 Saudi Arabia Parkinson Disease Drug Market Size, 2016-2027
        6.7.5 UAE Parkinson Disease Drug Market Size, 2016-2027
7 Players Profiles
    7.1 Merck
        7.1.1 Merck Corporate Summary
        7.1.2 Merck Business Overview
        7.1.3 Merck Parkinson Disease Drug Major Product Offerings
        7.1.4 Merck Parkinson Disease Drug Revenue in Global (2016-2021)
        7.1.5 Merck Key News
    7.2 Akorn
        7.2.1 Akorn Corporate Summary
        7.2.2 Akorn Business Overview
        7.2.3 Akorn Parkinson Disease Drug Major Product Offerings
        7.2.4 Akorn Parkinson Disease Drug Revenue in Global (2016-2021)
        7.2.5 Akorn Key News
    7.3 GSK
        7.3.1 GSK Corporate Summary
        7.3.2 GSK Business Overview
        7.3.3 GSK Parkinson Disease Drug Major Product Offerings
        7.3.4 GSK Parkinson Disease Drug Revenue in Global (2016-2021)
        7.3.5 GSK Key News
    7.4 Novartis
        7.4.1 Novartis Corporate Summary
        7.4.2 Novartis Business Overview
        7.4.3 Novartis Parkinson Disease Drug Major Product Offerings
        7.4.4 Novartis Parkinson Disease Drug Revenue in Global (2016-2021)
        7.4.5 Novartis Key News
    7.5 Boehringer Ingelheim
        7.5.1 Boehringer Ingelheim Corporate Summary
        7.5.2 Boehringer Ingelheim Business Overview
        7.5.3 Boehringer Ingelheim Parkinson Disease Drug Major Product Offerings
        7.5.4 Boehringer Ingelheim Parkinson Disease Drug Revenue in Global (2016-2021)
        7.5.5 Boehringer Ingelheim Key News
    7.6 Teva Pharmaceutical
        7.6.1 Teva Pharmaceutical Corporate Summary
        7.6.2 Teva Pharmaceutical Business Overview
        7.6.3 Teva Pharmaceutical Parkinson Disease Drug Major Product Offerings
        7.6.4 Teva Pharmaceutical Parkinson Disease Drug Revenue in Global (2016-2021)
        7.6.5 Teva Pharmaceutical Key News
    7.7 Abbvie
        7.7.1 Abbvie Corporate Summary
        7.7.2 Abbvie Business Overview
        7.7.3 Abbvie Parkinson Disease Drug Major Product Offerings
        7.4.4 Abbvie Parkinson Disease Drug Revenue in Global (2016-2021)
        7.7.5 Abbvie Key News
    7.8 Kyowa Hakko Kirin Pharma
        7.8.1 Kyowa Hakko Kirin Pharma Corporate Summary
        7.8.2 Kyowa Hakko Kirin Pharma Business Overview
        7.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Major Product Offerings
        7.8.4 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue in Global (2016-2021)
        7.8.5 Kyowa Hakko Kirin Pharma Key News
    7.9 Astellas Pharma
        7.9.1 Astellas Pharma Corporate Summary
        7.9.2 Astellas Pharma Business Overview
        7.9.3 Astellas Pharma Parkinson Disease Drug Major Product Offerings
        7.9.4 Astellas Pharma Parkinson Disease Drug Revenue in Global (2016-2021)
        7.9.5 Astellas Pharma Key News
    7.10 Desitin Arzneimittel
        7.10.1 Desitin Arzneimittel Corporate Summary
        7.10.2 Desitin Arzneimittel Business Overview
        7.10.3 Desitin Arzneimittel Parkinson Disease Drug Major Product Offerings
        7.10.4 Desitin Arzneimittel Parkinson Disease Drug Revenue in Global (2016-2021)
        7.10.5 Desitin Arzneimittel Key News
    7.11 Endo Pharmaceuticals
        7.11.1 Endo Pharmaceuticals Corporate Summary
        7.11.2 Endo Pharmaceuticals Business Overview
        7.11.3 Endo Pharmaceuticals Parkinson Disease Drug Major Product Offerings
        7.11.4 Endo Pharmaceuticals Parkinson Disease Drug Revenue in Global (2016-2021)
        7.11.5 Endo Pharmaceuticals Key News
    7.12 F.Hoffmann-La Roche
        7.12.1 F.Hoffmann-La Roche Corporate Summary
        7.12.2 F.Hoffmann-La Roche Business Overview
        7.12.3 F.Hoffmann-La Roche Parkinson Disease Drug Major Product Offerings
        7.12.4 F.Hoffmann-La Roche Parkinson Disease Drug Revenue in Global (2016-2021)
        7.12.5 F.Hoffmann-La Roche Key News
    7.13 H.Lundbeck
        7.13.1 H.Lundbeck Corporate Summary
        7.13.2 H.Lundbeck Business Overview
        7.13.3 H.Lundbeck Parkinson Disease Drug Major Product Offerings
        7.13.4 H.Lundbeck Parkinson Disease Drug Revenue in Global (2016-2021)
        7.13.5 H.Lundbeck Key News
    7.14 Valeant
        7.14.1 Valeant Corporate Summary
        7.14.2 Valeant Business Overview
        7.14.3 Valeant Parkinson Disease Drug Major Product Offerings
        7.14.4 Valeant Parkinson Disease Drug Revenue in Global (2016-2021)
        7.14.5 Valeant Key News
    7.15 Apokyn
        7.15.1 Apokyn Corporate Summary
        7.15.2 Apokyn Business Overview
        7.15.3 Apokyn Parkinson Disease Drug Major Product Offerings
        7.15.4 Apokyn Parkinson Disease Drug Revenue in Global (2016-2021)
        7.15.5 Apokyn Key News
    7.16 Orion
        7.16.1 Orion Corporate Summary
        7.16.2 Orion Business Overview
        7.16.3 Orion Parkinson Disease Drug Major Product Offerings
        7.16.4 Orion Parkinson Disease Drug Revenue in Global (2016-2021)
        7.16.5 Orion Key News
    7.17 Stada Arzneimittel
        7.17.1 Stada Arzneimittel Corporate Summary
        7.17.2 Stada Arzneimittel Business Overview
        7.17.3 Stada Arzneimittel Parkinson Disease Drug Major Product Offerings
        7.17.4 Stada Arzneimittel Parkinson Disease Drug Revenue in Global (2016-2021)
        7.17.5 Stada Arzneimittel Key News
    7.18 US WorldMeds
        7.18.1 US WorldMeds Corporate Summary
        7.18.2 US WorldMeds Business Overview
        7.18.3 US WorldMeds Parkinson Disease Drug Major Product Offerings
        7.18.4 US WorldMeds Parkinson Disease Drug Revenue in Global (2016-2021)
        7.18.5 US WorldMeds Key News
    7.19 Bausch Health
        7.19.1 Bausch Health Corporate Summary
        7.19.2 Bausch Health Business Overview
        7.19.3 Bausch Health Parkinson Disease Drug Major Product Offerings
        7.19.4 Bausch Health Parkinson Disease Drug Revenue in Global (2016-2021)
        7.19.5 Bausch Health Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com